EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study

Sacharias von Koch iD, Mikael Zhou iD, Hans Christian Rosén iD, Sammy Zwackman iD, Juliane Jurga iD, Per Grimfjärd iD, Matthias Götberg iD, Moman A Mohammad iD, David Erlinge iD

Journal of the American Heart Association · 22.11.2024

DOI: 10.1161/jaha.124.036839 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, online erschienen am 22.11.2024. Verfasst von Sacharias von Koch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund Sweden. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Restenosis, Coated Materials, Biocompatible. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty. We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty. Methods and Results We conducted a nationwide analysis from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) including in‐stent restenosis lesions undergoing coronary angiography between June 11, 2013, and January 14, 2022. The primary outcome of this study was target‐lesion revascularization within a 5‐year follow‐up. Secondary outcomes included all‐cause death, cardiovascular death, myocardial infarction, and any percutaneous coronary intervention. The outcomes were analyzed using a multivariable Cox proportional hazard model or Poisson regression, as appropriate. A total of 10 561 lesions from 9062 patients were included. Compared with plain old balloon angioplasty, the use of DCB angioplasty was associated with less target‐lesion revascularization (risk ratio, 0.69 [95% CI, 0.57–0.82]), all‐cause death (risk ratio, 0.72 [95% CI, 0.59–0.88]), and cardiovascular death (hazard ratio [HR], 0.59 [95% CI, 0.45–0.78]). No difference was observed for myocardial infarction or any percutaneous coronary intervention. Compared with drug‐eluting stents, the use of DCBs was associated with higher rates of target‐lesion revascularization (HR, 1.20 [95% CI, 1.06–1.37]). No difference was observed for all‐cause death, cardiovascular death, myocardial infarction, or any percutaneous coronary intervention.

Conclusions

In this long‐term nationwide analysis, the use of DCB angioplasty showed superior outcomes compared with plain old balloon angioplasty within 5 years but higher rates of repeat revascularizations compared with drug‐eluting stents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsAngioplasty, Balloon, CoronaryCoronary RestenosisCoated Materials, BiocompatibleRegistriesHumansMaleFemaleAgedMiddle AgedTreatment OutcomeTime FactorsCoronary AngiographyCardiac CathetersPercutaneous Coronary InterventionCoronary Artery DiseaseRisk Factors

Stichwörter der Autor:innen

drug‐coated balloondrug‐eluting stentin‐stent restenosisplain old balloon angioplastytarget‐lesion revascularization

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund Sweden.
  • Department of Health, Medicine and Caring Sciences and Department of Cardiology Linköping University Linköping Sweden.
  • Division of Cardiology, Department of Medicine Karolinska Institute and Karolinska University Hospital Stockholm Sweden.
  • Department of Internal Medicine Västmanlands Hospital Västerås Sweden.

ORCID-Profile: Sacharias von Koch, Mikael Zhou, Hans Christian Rosén, Sammy Zwackman, Juliane Jurga, Per Grimfjärd, Matthias Götberg, Moman A Mohammad, David Erlinge

Zitieren

APA

von Koch, S., Zhou, M., Rosén, H. C., Zwackman, S., Jurga, J., Grimfjärd, P., Götberg, M., Mohammad, M. A., & Erlinge, D. (2024). Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036839

Vancouver

von Koch S, Zhou M, Rosén HC, Zwackman S, Jurga J, Grimfjärd P, et al. Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.036839

BibTeX
@article{vonKoch2024,
  author = {von Koch, Sacharias and Zhou, Mikael and Rosén, Hans Christian and Zwackman, Sammy and Jurga, Juliane and Grimfjärd, Per and Götberg, Matthias and Mohammad, Moman A and Erlinge, David},
  title = {Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.036839}
}
Kostenlos starten →